Editorial: Health technology assessment in cardiovascular diseases.
作者信息
Shah Komal, Sharma Kamal, Saxena Deepak
机构信息
Department of Public Health, Indian Institute of Public Health Gandhinagar, Gandhinagar, Gujarat, India.
Department of Cardiology, SAL Hospital, Ahmedabad, India.
出版信息
Front Cardiovasc Med. 2023 Jan 24;10:1108503. doi: 10.3389/fcvm.2023.1108503. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Health technology assessment in cardiovascular diseases.社论：心血管疾病的卫生技术评估
Front Cardiovasc Med. 2023 Jan 24;10:1108503. doi: 10.3389/fcvm.2023.1108503. eCollection 2023.
2
Evidence-Based Decision Making 3: Health Technology Assessment.循证决策 3：卫生技术评估。
Methods Mol Biol. 2021;2249:429-454. doi: 10.1007/978-1-0716-1138-8_23.
3
Health technology assessment in India: the potential for improved healthcare decision-making.印度的卫生技术评估：改善医疗保健决策的潜力。
Natl Med J India. 2014 May-Jun;27(3):159-63.
4
Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.开发一个决策支持系统，将卫生技术评估（HTA）报告与伊朗的卫生系统政策相联系。
Health Policy Plan. 2017 May 1;32(4):504-515. doi: 10.1093/heapol/czw160.
5
HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations.医疗保健专业人员 HTA 培训：HTA 机构和组织提供的国际计划概述。
Front Public Health. 2022 Feb 10;10:795763. doi: 10.3389/fpubh.2022.795763. eCollection 2022.
6
HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.土耳其的卫生技术评估。
Int J Technol Assess Health Care. 2017 Jan;33(3):402-408. doi: 10.1017/S0266462317000289. Epub 2017 Jun 9.
7
Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan.中低收入国家实施卫生技术评估的路线图：以约旦为例。
Value Health Reg Issues. 2021 Sep;25:126-134. doi: 10.1016/j.vhri.2021.01.003. Epub 2021 May 18.
8
Development of health technology assessment in Lithuania.立陶宛卫生技术评估的发展
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:140-2. doi: 10.1017/S0266462309090552.
9
AGING AND HEALTH TECHNOLOGY ASSESSMENT: AN IDEA WHOSE TIME HAS COME.衰老与健康技术评估：恰逢其时的理念。
Int J Technol Assess Health Care. 2018 Jan;34(5):442-446. doi: 10.1017/S0266462318000600.
10
Evaluating Public Health Interventions: A Neglected Area in Health Technology Assessment.评估公共卫生干预措施：卫生技术评估中的一个被忽视领域。
Front Public Health. 2020 Apr 22;8:106. doi: 10.3389/fpubh.2020.00106. eCollection 2020.
引用本文的文献
1
The effects of the mediterranean diet supplemented with olive oils on pro-inflammatory biomarkers and soluble adhesion molecules: a systematic review and meta-analysis of randomized controlled trials.补充橄榄油的地中海饮食对促炎生物标志物和可溶性黏附分子的影响：一项随机对照试验的系统评价和荟萃分析
Nutr Metab (Lond). 2025 May 26;22(1):52. doi: 10.1186/s12986-025-00947-8.
2
The Effects of Apple Cider Vinegar on Cardiometabolic Risk Factors: A Systematic Review and Meta-analysis of Clinical Trials.苹果醋对心脏代谢危险因素的影响：一项临床试验的系统评价和荟萃分析
Curr Med Chem. 2025;32(11):2257-2274. doi: 10.2174/0929867331666230822102021.
本文引用的文献
1
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.超越 10 年风险：他汀类药物用于心血管疾病一级预防的成本效益分析。
Circulation. 2022 Apr 26;145(17):1312-1323. doi: 10.1161/CIRCULATIONAHA.121.057631. Epub 2022 Mar 7.
2
Cost-effectiveness of left ventricular assist devices as destination therapy in the United Kingdom.英国左心室辅助装置作为终末期心衰治疗的成本效益分析
ESC Heart Fail. 2021 Aug;8(4):3049-3057. doi: 10.1002/ehf2.13401. Epub 2021 May 27.
3
The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016.印度各邦心血管疾病及其危险因素的变化模式：1990-2016 年全球疾病负担研究。
Lancet Glob Health. 2018 Dec;6(12):e1339-e1351. doi: 10.1016/S2214-109X(18)30407-8. Epub 2018 Sep 12.
4
The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review.低收入和中等收入国家心血管疾病和高血压的经济负担：系统评价。
BMC Public Health. 2018 Aug 6;18(1):975. doi: 10.1186/s12889-018-5806-x.
Zotero 插件